Clinical value of preoperative serum PCSK9 detection combined with TyG index and TG/HDL-c ratio in patients with breast cancer
Objective:To investigate the clinical value of preoperative serum protein convertase subtilisin/kexin type 9(PCSK9)detection combined with triglyceride-glucose(TyG)index and triglyceride-high-density lipoprotein cholesterol(TG/HDL-c)ratio in patients with breast cancer.Methods:The complete medical records were obtained from 122 cases of breast cancer confirmed by pathology and treated surgically,76 cases of benign breast tumors removed surgically,and 105 cases of healthy subjects undergoing physical examination in our hospital.The data in each group were statistically analyzed.ROC curve was used to determine the optimal threshold of serum PCSK9,TyG and TG/HDL-c,and their clinical value in predicting the prognosis of breast cancer patients was analyzed.Results:The serum levels of PCSK9,TyG index and TG/HDL-c ratio in benign tumor group and healthy control group were significantly lower than those in breast cancer group(P<0.05).The corrected multivariate logistic regression analysis showed that elevated serum TyG index(OR=2.766,95%CI:1.449-5.278),TG/HDL-c ratio(OR=28.624,95%CI:5.055-162.094)and PCSK9 level(OR=1.082,95%CI:1.060-1.105)were all risk factors for breast cancer(P<0.001).The ROC curve showed that combined analysis of serum PCSK9,TyG index and TG/HDL-c ratio(AUC=0.905)had significantly higher diagnostic accuracy than TyG index(AUC=0.797)and TG/HDL-c ratio(AUC=0.713)alone(P<0.01).Conclusion:Serum PCSK9,TyG index and TG/HDL-c ratio can serve as auxiliary diagnostic indicators for breast cancer patients.High levels of serum PCSK9,TyG and TG/HDL-c indicate poor prognosis for patients.
serum protein convertase subtilisin/kexin type 9triglyceride-glucose indextriglyceride-high-density lipoprotein cholesterol ratiobreast cancer